# Ascertain

> Ascertain develops AI agents and provides operational support to automate healthcare administration for health systems, payers, and provider groups. Built with Northwell Health and Aegis Ventures, it handles work such as prior authorizations, eligibility checks, documentation, and payer communication.

- **Founded:** 2022
- **Headquarters:** New York, United States
- **Founders:** Northwell Holdings (Institutional founding partner), Aegis Ventures (Institutional founding partner)
- **Products:** Ascertain Automate, Tech-Enabled Services, Unified Payer Portal (UPP), Ascertain Assistants
- **Notable:** Northwell pilot: company-reported 80% fewer user clicks and 67% shorter authorization submission time., TOI pilot sites: reported over 80% reduction in office-visit authorization submission time after September 2025 launch., Named to the 2026 New York Digital Health 100.

## Products & services

- **Ascertain Automate** — Enterprise automation offering described in the 2025 DHNY innovation report; automates high-volume healthcare administrative work.
- **Tech-Enabled Services** — Operational services supporting healthcare workflows alongside automation; described in the 2025 DHNY innovation report.
- **Unified Payer Portal (UPP)** — AI automation module for payer portal navigation, data entry, and documentation submission ahead of outpatient visits.
- **Ascertain Assistants** — Healthcare operations specialists involved in sales, implementation, ongoing support, and exceptions.

## Achievements

- Northwell pilot: company-reported 80% fewer user clicks and 67% shorter authorization submission time.
- TOI pilot sites: reported over 80% reduction in office-visit authorization submission time after September 2025 launch.
- Named to the 2026 New York Digital Health 100.

## Latest updates

- **2026-07** — Published analysis of disparities in prior authorization approvals and delays.
- **2026-02** — Announced inclusion in the New York Digital Health 100.
- **2026-01** — Announced CVAUSA automation partnership.
- **2025-11** — Announced TOI co-development results and an estimate of up to $2 million in 2026 operating expense savings, a projection rather than realized savings.
- **2025-10** — Appointed Molly O’Neill Chief Commercial Officer.

## Links

- Website: https://www.ascertain.com/
- LinkedIn: https://www.linkedin.com/company/ascertain-ai/

---

Profile page: https://yespress.io/ascertain
Published by YesPress — https://yespress.io
Last updated: 2026-10-05